QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outst...

 nasdaq-down-over-1-us-initial-jobless-claims-fall

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 1% on Thursday. Following the market open...

Core News & Articles

Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session. The market value of their ...

 why-pepgen-shares-are-trading-higher-by-112-here-are-20-stocks-moving-premarket

Shares of PepGen Inc. (NASDAQ: PEPG) rose sharply in pre-market trading after the company announced the launch of an underwritt...

 seastar-medical-announces-that-independent-dsmb-recommends-continuing-neutralize-aki-pivotal-trial-of-its-selective-cytopheretic-device-therapy-for-adult-patients-with-acute-kidney-injury-requiring-continuous-renal-replacement-therapy

SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for ...

 seastar-medical-to-present-preliminary-save-surveillance-registry-data-on-quelimmune-therapy-for-pediatric-aki-and-sepsis-at-the-5th-international-symposium-on-acute-kidney-injury-in-children

SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company, announced today that preliminary resul...

 seastar-medical-highlights-69146-cost-savings-with-quelimmune-therapy-in-pediatric-aki-published-in-journal-of-medical-economics

SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for ...

 seastar-medical-announces-it-has-terminated-cfo-david-green-eric-schlorff-appointed-interim-cfo

- SEC Filing

 seastar-medical-holding-q2-eps-018-beats-043-estimate-sales-338000k-beat-200000k-estimate

SeaStar Medical Holding (NASDAQ:ICU) reported quarterly losses of $(0.18) per share which beat the analyst consensus estimate o...

 seastar-medical-announces-44m-offering-of-496m-shares-at-0887share-in-a-concurrent-private-placement-co-will-issue-and-sell-unregistered-warrants-to-purchase-up-to-496m-shares-of-common-stock

SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for ...

 seastar-medical-reports-early-results-for-quelimmune-in-pediatric-aki-and-sepsis-showing-75-survival-and-no-device-related-safety-events

SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company, announced today positive preliminary r...

 seastar-medical-announces-4m-offering-of-524m-shares-at-0763-each-plus-warrants-for-524m-shares-at-0638-in-concurrent-private-placement

SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for ...

 seastar-medical-holding-says-quelimmune-therapy-adopted-for-use-by-nationally-recognized-texas-childrens-hospital

SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION